343 related articles for article (PubMed ID: 12915716)
1. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
Keys DA; Bruckner JV; Muralidhara S; Fisher JW
Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
Greenberg MS; Burton GA; Fisher JW
Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
[TBL] [Abstract][Full Text] [Related]
3. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
Abbas R; Fisher JW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue.
Albanese RA; Banks HT; Evans MV; Potter LK
Bull Math Biol; 2002 Jan; 64(1):97-131. PubMed ID: 11868339
[TBL] [Abstract][Full Text] [Related]
5. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
Evans MV; Chiu WA; Okino MS; Caldwell JC
Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323
[TBL] [Abstract][Full Text] [Related]
6. Dose-based duration adjustments for the effects of inhaled trichloroethylene on rat visual function.
Boyes WK; Bercegeay M; Ali JS; Krantz T; McGee J; Evans M; Raymer JH; Bushnell PJ; Simmons JE
Toxicol Sci; 2003 Nov; 76(1):121-30. PubMed ID: 12915717
[TBL] [Abstract][Full Text] [Related]
7. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
Bogen KT; Gold LS
Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
[TBL] [Abstract][Full Text] [Related]
8. Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.
Sanzgiri UY; Srivatsan V; Muralidhara S; Dallas CE; Bruckner JV
Toxicol Appl Pharmacol; 1997 Mar; 143(1):120-9. PubMed ID: 9073600
[TBL] [Abstract][Full Text] [Related]
9. A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat.
Simmons JE; Boyes WK; Bushnell PJ; Raymer JH; Limsakun T; McDonald A; Sey YM; Evans MV
Toxicol Sci; 2002 Sep; 69(1):3-15. PubMed ID: 12215655
[TBL] [Abstract][Full Text] [Related]
10. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
Fisher JW; Mahle D; Abbas R
Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
[TBL] [Abstract][Full Text] [Related]
11. Momentary brain concentration of trichloroethylene predicts the effects on rat visual function.
Boyes WK; Bercegeay M; Krantz T; Evans M; Benignus V; Simmons JE
Toxicol Sci; 2005 Sep; 87(1):187-96. PubMed ID: 15976185
[TBL] [Abstract][Full Text] [Related]
12. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
13. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose metrics.
Yoon M; Madden MC; Barton HA
J Toxicol Environ Health A; 2007 Sep; 70(18):1527-41. PubMed ID: 17710613
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
[TBL] [Abstract][Full Text] [Related]
15. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
[TBL] [Abstract][Full Text] [Related]
16. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
[TBL] [Abstract][Full Text] [Related]
17. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans.
Pastino GM; Asgharian B; Roberts K; Medinsky MA; Bond JA
Toxicol Appl Pharmacol; 1997 Jul; 145(1):147-57. PubMed ID: 9221833
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacodynamic modeling of an interaction threshold between trichloroethylene and 1,1-dichloroethylene in Fischer 344 rats.
el-Masri HA; Constan AA; Ramsdell HS; Yang RS
Toxicol Appl Pharmacol; 1996 Nov; 141(1):124-32. PubMed ID: 8917684
[TBL] [Abstract][Full Text] [Related]
19. Presystemic elimination of trichloroethylene in rats following environmentally relevant oral exposures.
Liu Y; Bartlett MG; White CA; Muralidhara S; Bruckner JV
Drug Metab Dispos; 2009 Oct; 37(10):1994-8. PubMed ID: 19581386
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat.
Lilly PD; Andersen ME; Ross TM; Pegram RA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):205-17. PubMed ID: 9653052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
